Expression of eIF5A1 has previously been correlated to p53 levels in lung cancer cells [11,14], and in this study a dose-dependent increase in p53 was observed in response to Ad-eIF5A1 and Ad-eIF5A1K50A infection in A549 cells (Figures 1B and 3). The gene discussed is TP53; the disease is lung carcinoma.